Symptoms Of Lymphoma In Children

Symptoms of lymphoma in children are generally non-specific, meaning that they could indicate health problems other than lymphoma. Regardless, they should be brought to the attention of a physician or health professional as soon as possible so that the proper tests can be carried out and the determination be made.

Symptoms of lymphoma in children are, in no particular order:

  • Swollen, painless lymph nodes in the neck, groin, stomach or armpit
  • Unexplained fevers
  • Unexplained weight loss
  • Drenching night sweats
  • Swelling of the head or neck
  • Difficulty breathing
  • Wheezing
  • Shortness of breath
  • Difficulty swallowing

If a child exhibits one or more of these symptoms, he or she should be seen by a physician immediately for a proper examination. Tests that may be required include biopsy, chest x-ray and CT scans.

Sources

  • National Cancer Institute
  • Medscape reference
  • MacMillan Cancer Support

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap